tyrosine

Tyrosine kinase inhibitor is a tyrosine kinase inhibitor used in combination with fragmenting aromatic nitrogen compounds as antiproliferative agents.

DL-m-Tyrosine exhibits effects on Arabidopsis root growth.

L-Tyrosine-13C9,15N is intended for use as an internal standard for the quantification of L-tyrosine by GC- or LC-MS. L-Tyrosine is a non-essential amino acid.1It is produced by hydroxylation of phenylalanine by phenylalanine hydroxylase but can also be obtained from dietary sources or degradation of endogenous proteins, resulting in L-tyrosine release.1,2L-Tyrosine is a precursor in the biosynthesis of catecholamine neurotransmitters, melanins, and thyroid hormones.3Plasma, skeletal muscle, and erythrocyte levels of L-tyrosine are decreased in patients with chronic kidney disease.1 1.Kopple, J.D.Phenylalanine and tyrosine metabolism in chronic kidney failureJ. Nutr.137(6 Suppl 1)1586S-1590S(2007) 2.Webster, D., and Wildgoose, J.Tyrosine supplementation for phenylketonuriaCochrane DB Syst. Rev.2013(6)CD001507(2013) 3.Slominski, A., and Paus, R.Towards defining receptors for L-tyrosine and L-DOPAMol. Cell Endocrinol.99(2)C7-C11(1994)

Certain chronic neurologic disorders, such as Parkinson's disease, are caused by an insufficiency of the neurotransmitter dopamine secondary to the degeneration of substantia nigra dopaminergic neurons. N-(α-Linolenoyl) tyrosine (NALT) is a simple α-amide conjugate between the ω-3 essential fatty acid α-linolenate and the amino acid tyrosine. α-Linolenate is an important precursor to docosahexaenoic acid (DHA), a prominent brain polyunsaturated fatty acid, while tyrosine is the metabolic precursor for neuronal dopamine synthesis. NALT was prepared as a method for enhancing central nervous system (CNS) dopamine content by facilitated transport of the tyrosine precursor across the blood-brain barrier. In experimental rat models of dopamine insufficiency, NALT increased CNS dopamine levels and exhibited an activity profile consistent with an anti-Parkinson's therapeutic agent.

Tyrosine Kinase Peptide 1 is a control substrate peptide used in c-Src assay.

EGFR Protein Tyrosine Kinase Substrate is an EGFR protein tyrosine kinase substrate.

L-Tyrosine-13C9,15N (Standard) is a reference standard of L-Tyrosine-13C9,15N intended for quantitative analysis, quality control, and related biochemical research applications. L-Tyrosine-13C9,15N is used as an internal standard for quantitative analysis of L-tyrosine by gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry. L-Tyrosine is a non-essential amino acid.

Tyrosine Protein Kinase JAK 2 (Phospho-Tyr8, 9) is a peptide derived from mouse JAK2, consisting of amino acids 475 to 491.

N-Acetyl-L-tyrosine ethyl ester (ATEE) is a compound frequently used as a food flavoring agent and supplement. It is an ester of tyrosine, an amino acid found in various proteins. ATEE imparts sweetness, nuttiness, and a caramel-like flavor, enhancing the taste of baked goods, dairy products, and beverages. It also offers potential health benefits, such as antioxidant properties and the ability to improve cognitive function.

3-Iodo-Tyrosine-CoA (3-Iodo-Tyrosine-coenzyme A) is a derivative of coenzyme A.

L-Tyrosine-CoA (L-Tyrosine-coenzyme A) is a derivative of coenzyme A.

Meta-tyrosine-CoA (Meta-tyrosine-coenzyme A) is a derivative of coenzyme A.

L-Tyrosine ((S)-Tyrosine) is a naturally occurring tyrosine and is synthesized in vivo from L-phenylalanine, considered a non-essential amino acid. L-Tyrosine(L-p-Tyrosine) is the levorotatory isomer of the aromatic amino acid tyrosine.

L-m-Tyrosine (3-Hydroxy-L-Phenylalanine) is a non-natural amino acid. L-(-)-m-Tyrosine displays the potential in treating Parkinson's disease, arthritis, and Alzheimer's disease.

3-Nitro-L-tyrosine (3-Nitrotyrosine) is the major product from the spontaneous reaction of peroxynitrite with tyrosine. Formation of nitrotyrosine can indicate the formation of peroxynitrite by a nitric oxide (NO)-dependent oxidative damage.

3-Chloro-L-Tyrosine (Chlorotyrosine), a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low-density lipoprotein isolated from human atherosclerotic intima. In particular, myeloperoxidase halogenates tyrosine residues in plasma proteins and generates 3-chlorotyrosine (CY). The detection of free chlorotyrosine in blood or urine arises from the degradation of these chlorinated proteins. CY concentrations may be useful for monitoring the activation of neutrophils in asthmatic patients.

N-Acetyl-L-tyrosine (Ac-Tyr-OH) is a side chain reaction of tyrosine. It converts to tyrosine and then can be used in neurotransmitter treatment as a precursor of cathecholamine.

D-Tyrosine, the D-isomer of tyrosine, acts as a negative regulator of melanin synthesis by inhibiting tyrosinase activity. Furthermore, D-Tyrosine also inhibits biofilm formation and induces the self-dispersal of biofilms, while not affecting bacterial growth.

DL-Tyrosine is a natural product.

L-Tyrosine methyl ester is a tyrosine derivative and endogenous metabolite, applicable for encapsulating carbon-dot fluorescent probes in metal-free thiol-based assays.

N-Stearoyltyrosine (N-(1-Oxooctadecyl)-L-tyrosine) is an analog of Anandamide. It exhibits neuroprotective effects by safeguarding the CA1 region of the hippocampus in a gerbil ischemia-reperfusion model. Additionally, N-Stearoyltyrosine inhibits free radical generation, enhances antioxidant capacity, and reduces IR-induced apoptosis (cell apoptosis).

N-benzoyl tyrosine is a dipeptide.

Glycyltyrosine, a dipeptide composed of tyrosine and glycine, is an incomplete breakdown product of protein catabolism or protein digestion.

Tyrosyltyrosine is a dipeptide.